Single‐Atom Nanozymes for High‐Efficiency Cancer Immunotherapy by Targeting Tumor Microenvironment
Tumor immunotherapy has emerged as a transformative strategy for cancer treatment. However, its clinical efficacy remains limited by the immunosuppressive tumor microenvironment (TME), which restricts immune cells infiltration, suppresses effector cells activity, and promotes immune escape. Recent advances in catalytic...